Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,454 | 35,729 | 28,871 | 36,037 | 23,044 |
| Marketable Securities | 670,133 | 415,729 | 489,702 | 547,186 | 607,293 |
| Receivables | 230 | 230 | 2,015 | 90 | 90 |
| TOTAL | $724,931 | $459,222 | $534,664 | $604,339 | $648,404 |
| Non-Current Assets | |||||
| PPE Net | 9,756 | 7,396 | 5,334 | 4,829 | 4,392 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 27,190 |
| Other Non-Current Assets | 20,472 | 17,446 | 15,795 | 12,081 | 12,421 |
| TOTAL | $57,418 | $52,032 | $48,319 | $44,100 | $44,003 |
| Total Assets | $782,349 | $511,254 | $582,983 | $648,439 | $692,407 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,230 | N/A | 1,230 | N/A | N/A |
| Accounts payable and accrued liabilities | 14,675 | 10,359 | 1,180 | 4,267 | 2,073 |
| Accrued Expenses | 43,863 | 38,418 | 47,029 | 39,715 | 28,424 |
| Other current liabilities | N/A | 1,230 | N/A | 930 | 930 |
| TOTAL | $61,325 | $51,472 | $50,991 | $46,465 | $32,963 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,460 | 3,556 | 4,827 | 3,611 | 4,038 |
| TOTAL | $6,460 | $3,556 | $4,827 | $3,611 | $4,038 |
| Total Liabilities | $67,785 | $55,028 | $55,818 | $50,076 | $37,001 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,530 | 78,492 | 66,566 | 66,449 | 66,407 |
| Common Shares | 79 | 67 | 67 | 66 | 66 |
| Retained earnings | -1,966,169 | -1,892,666 | -1,813,981 | -1,732,664 | -1,665,620 |
| Other shareholders' equity | 1,298 | 2,522 | 3,626 | 3,765 | 3,339 |
| TOTAL | $714,564 | $456,226 | $527,165 | $598,363 | $655,406 |
| Total Liabilities And Equity | $782,349 | $511,254 | $582,983 | $648,439 | $692,407 |